Last reviewed · How we verify

Chloroprocaine 3% — Competitive Intelligence Brief

Chloroprocaine 3% (Chloroprocaine 3%) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Local anesthetic (ester). Area: Anesthesia.

phase 3 Local anesthetic (ester) Voltage-gated sodium channels Anesthesia Small molecule Live · refreshed every 30 min

Target snapshot

Chloroprocaine 3% (Chloroprocaine 3%) — Sintetica SA. Chloroprocaine is a local anesthetic that blocks sodium channels in nerve cell membranes, preventing the initiation and propagation of nerve impulses.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Chloroprocaine 3% TARGET Chloroprocaine 3% Sintetica SA phase 3 Local anesthetic (ester) Voltage-gated sodium channels
Anesthetics, Local Anesthetics, Local University of Alberta marketed Local anesthetic Voltage-gated sodium channels
Infiltration - EXPAREL Infiltration - EXPAREL Pacira Pharmaceuticals, Inc marketed Long-acting local anesthetic Voltage-gated sodium channels
Lidocaine 2% Injectable Solution Lidocaine 2% Injectable Solution Erasme University Hospital marketed Local anesthetic Voltage-gated sodium channels
Lidocaine 2% Jelly Lidocaine 2% Jelly Hermann Eye Center marketed Local anesthetic Voltage-gated sodium channels
Levobupivacaine and Fentanyl Levobupivacaine and Fentanyl Hamad Medical Corporation marketed Local anesthetic with opioid analgesic combination Voltage-gated sodium channels; mu-opioid receptor
Lidocaine plus adrenaline Lidocaine plus adrenaline University of Santiago de Compostela marketed Local anesthetic with vasopressor Voltage-gated sodium channels; alpha-1 and beta-1 adrenergic receptors

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Local anesthetic (ester) class)

  1. Sintetica SA · 4 drugs in this class
  2. Centre Hospitalier Universitaire Saint Pierre · 1 drug in this class
  3. Nova Scotia Health Authority · 1 drug in this class
  4. American Genomics, LLC · 1 drug in this class
  5. University of Miami · 1 drug in this class
  6. Wenzhou Medical University · 1 drug in this class
  7. Oregon Health and Science University · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Chloroprocaine 3% — Competitive Intelligence Brief. https://druglandscape.com/ci/chloroprocaine-3. Accessed 2026-06-10.

Build your own brief

Pick any drug + add comparators:

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing